Changes in expression of oestrogen regulated and proliferation genes with neoadjuvant treatment highlight heterogeneity of clinical resistance to the aromatase inhibitor, letrozole.

Highly significant positive correlations were detected between the two methodologies for each gene (including responding cases from the total database greatly increases the number of sample comparisons and the P- values are < 10 -15 for each gene).

also in 132,142 other papers